- Home
- HYFT vs INCR Comparison
HYFT vs INCR Comparison
Compare HYFT & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HYFT | INCR |
|---|---|---|
| Founded | 1983 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.5M | 58.6M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HYFT | INCR |
|---|---|---|
| Price | $1.14 | $4.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.33 | N/A |
| AVG Volume (30 Days) | ★ 289.9K | 3.2K |
| Earning Date | 12-14-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.86 | $204.79 |
| Revenue Next Year | $22.94 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.99 | $0.68 |
| 52 Week High | $3.00 | $6.10 |
Technical Indicators
Market Signals| Indicator | HYFT | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 37.93 | 34.99 |
| Support Level | $1.03 | $0.81 |
| Resistance Level | $1.50 | $5.58 |
| Average True Range (ATR) | 0.10 | 0.26 |
| MACD | -0.02 | -0.10 |
| Stochastic Oscillator | 12.50 | 8.16 |
Price Performance
Historical ComparisonAbout HYFT MindWalk Holdings Corp.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.